Carries a conserved CRAL-TRIO domain. Its didtant homologs are cytoplasmic and are involved in antiviral response.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 37 |
NetGPI | no | yes: 0, no: 37 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3S7X4P4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 3 | 7 | PF00656 | 0.543 |
CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.497 |
CLV_NRD_NRD_1 | 342 | 344 | PF00675 | 0.412 |
CLV_NRD_NRD_1 | 373 | 375 | PF00675 | 0.396 |
CLV_NRD_NRD_1 | 376 | 378 | PF00675 | 0.477 |
CLV_NRD_NRD_1 | 379 | 381 | PF00675 | 0.473 |
CLV_NRD_NRD_1 | 490 | 492 | PF00675 | 0.409 |
CLV_NRD_NRD_1 | 75 | 77 | PF00675 | 0.557 |
CLV_PCSK_FUR_1 | 374 | 378 | PF00082 | 0.444 |
CLV_PCSK_FUR_1 | 488 | 492 | PF00082 | 0.288 |
CLV_PCSK_KEX2_1 | 373 | 375 | PF00082 | 0.389 |
CLV_PCSK_KEX2_1 | 376 | 378 | PF00082 | 0.472 |
CLV_PCSK_KEX2_1 | 379 | 381 | PF00082 | 0.473 |
CLV_PCSK_KEX2_1 | 490 | 492 | PF00082 | 0.484 |
CLV_PCSK_KEX2_1 | 75 | 77 | PF00082 | 0.551 |
CLV_PCSK_SKI1_1 | 174 | 178 | PF00082 | 0.337 |
CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.302 |
CLV_PCSK_SKI1_1 | 236 | 240 | PF00082 | 0.464 |
CLV_PCSK_SKI1_1 | 264 | 268 | PF00082 | 0.369 |
CLV_PCSK_SKI1_1 | 284 | 288 | PF00082 | 0.344 |
CLV_PCSK_SKI1_1 | 307 | 311 | PF00082 | 0.421 |
CLV_PCSK_SKI1_1 | 314 | 318 | PF00082 | 0.395 |
CLV_PCSK_SKI1_1 | 35 | 39 | PF00082 | 0.461 |
CLV_Separin_Metazoa | 188 | 192 | PF03568 | 0.231 |
DOC_CYCLIN_yCln2_LP_2 | 54 | 57 | PF00134 | 0.523 |
DOC_MAPK_gen_1 | 171 | 181 | PF00069 | 0.338 |
DOC_MAPK_gen_1 | 29 | 36 | PF00069 | 0.467 |
DOC_MAPK_HePTP_8 | 266 | 278 | PF00069 | 0.279 |
DOC_MAPK_MEF2A_6 | 269 | 278 | PF00069 | 0.462 |
DOC_PP1_RVXF_1 | 321 | 328 | PF00149 | 0.316 |
DOC_PP1_RVXF_1 | 495 | 502 | PF00149 | 0.351 |
DOC_PP2B_LxvP_1 | 54 | 57 | PF13499 | 0.601 |
DOC_PP4_FxxP_1 | 438 | 441 | PF00568 | 0.356 |
DOC_USP7_MATH_1 | 237 | 241 | PF00917 | 0.384 |
DOC_USP7_MATH_1 | 469 | 473 | PF00917 | 0.501 |
DOC_USP7_UBL2_3 | 284 | 288 | PF12436 | 0.219 |
DOC_WW_Pin1_4 | 140 | 145 | PF00397 | 0.330 |
DOC_WW_Pin1_4 | 299 | 304 | PF00397 | 0.275 |
LIG_14-3-3_CanoR_1 | 129 | 136 | PF00244 | 0.392 |
LIG_14-3-3_CanoR_1 | 449 | 455 | PF00244 | 0.514 |
LIG_APCC_ABBA_1 | 276 | 281 | PF00400 | 0.393 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.671 |
LIG_BRCT_BRCA1_1 | 471 | 475 | PF00533 | 0.594 |
LIG_deltaCOP1_diTrp_1 | 94 | 101 | PF00928 | 0.494 |
LIG_FHA_1 | 131 | 137 | PF00498 | 0.411 |
LIG_FHA_1 | 161 | 167 | PF00498 | 0.490 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.614 |
LIG_FHA_1 | 216 | 222 | PF00498 | 0.428 |
LIG_FHA_1 | 395 | 401 | PF00498 | 0.396 |
LIG_FHA_1 | 435 | 441 | PF00498 | 0.362 |
LIG_FHA_1 | 85 | 91 | PF00498 | 0.228 |
LIG_FHA_2 | 1 | 7 | PF00498 | 0.667 |
LIG_FHA_2 | 240 | 246 | PF00498 | 0.454 |
LIG_FHA_2 | 337 | 343 | PF00498 | 0.426 |
LIG_FHA_2 | 449 | 455 | PF00498 | 0.338 |
LIG_FHA_2 | 89 | 95 | PF00498 | 0.221 |
LIG_Integrin_isoDGR_2 | 172 | 174 | PF01839 | 0.198 |
LIG_LIR_Apic_2 | 436 | 441 | PF02991 | 0.392 |
LIG_LIR_Gen_1 | 205 | 215 | PF02991 | 0.386 |
LIG_LIR_Gen_1 | 397 | 404 | PF02991 | 0.425 |
LIG_LIR_Gen_1 | 432 | 443 | PF02991 | 0.447 |
LIG_LIR_Gen_1 | 49 | 57 | PF02991 | 0.350 |
LIG_LIR_Nem_3 | 39 | 44 | PF02991 | 0.467 |
LIG_LIR_Nem_3 | 397 | 402 | PF02991 | 0.417 |
LIG_LIR_Nem_3 | 432 | 438 | PF02991 | 0.391 |
LIG_LIR_Nem_3 | 49 | 54 | PF02991 | 0.483 |
LIG_OCRL_FandH_1 | 493 | 505 | PF00620 | 0.296 |
LIG_Pex14_2 | 122 | 126 | PF04695 | 0.338 |
LIG_Pex14_2 | 435 | 439 | PF04695 | 0.339 |
LIG_REV1ctd_RIR_1 | 284 | 290 | PF16727 | 0.194 |
LIG_SH2_CRK | 224 | 228 | PF00017 | 0.371 |
LIG_SH2_CRK | 308 | 312 | PF00017 | 0.364 |
LIG_SH2_CRK | 41 | 45 | PF00017 | 0.452 |
LIG_SH2_PTP2 | 399 | 402 | PF00017 | 0.495 |
LIG_SH2_SRC | 345 | 348 | PF00017 | 0.397 |
LIG_SH2_STAP1 | 308 | 312 | PF00017 | 0.215 |
LIG_SH2_STAT3 | 367 | 370 | PF00017 | 0.305 |
LIG_SH2_STAT5 | 345 | 348 | PF00017 | 0.361 |
LIG_SH2_STAT5 | 399 | 402 | PF00017 | 0.413 |
LIG_SH2_STAT5 | 461 | 464 | PF00017 | 0.460 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.502 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.376 |
LIG_SH3_1 | 40 | 46 | PF00018 | 0.308 |
LIG_SH3_2 | 369 | 374 | PF14604 | 0.547 |
LIG_SH3_3 | 297 | 303 | PF00018 | 0.370 |
LIG_SH3_3 | 366 | 372 | PF00018 | 0.516 |
LIG_SH3_3 | 40 | 46 | PF00018 | 0.450 |
LIG_SH3_3 | 71 | 77 | PF00018 | 0.693 |
LIG_SUMO_SIM_anti_2 | 202 | 209 | PF11976 | 0.351 |
LIG_SUMO_SIM_anti_2 | 479 | 486 | PF11976 | 0.405 |
LIG_SUMO_SIM_par_1 | 213 | 220 | PF11976 | 0.248 |
LIG_TYR_ITIM | 176 | 181 | PF00017 | 0.391 |
LIG_TYR_ITIM | 222 | 227 | PF00017 | 0.282 |
LIG_TYR_ITIM | 306 | 311 | PF00017 | 0.444 |
LIG_UBA3_1 | 189 | 194 | PF00899 | 0.399 |
LIG_UBA3_1 | 33 | 38 | PF00899 | 0.529 |
LIG_WRC_WIRS_1 | 181 | 186 | PF05994 | 0.190 |
LIG_WRC_WIRS_1 | 435 | 440 | PF05994 | 0.413 |
MOD_CDC14_SPxK_1 | 143 | 146 | PF00782 | 0.326 |
MOD_CDK_SPK_2 | 140 | 145 | PF00069 | 0.330 |
MOD_CDK_SPxK_1 | 140 | 146 | PF00069 | 0.319 |
MOD_CK1_1 | 326 | 332 | PF00069 | 0.389 |
MOD_CK1_1 | 459 | 465 | PF00069 | 0.446 |
MOD_CK1_1 | 88 | 94 | PF00069 | 0.351 |
MOD_CK2_1 | 180 | 186 | PF00069 | 0.431 |
MOD_CK2_1 | 213 | 219 | PF00069 | 0.410 |
MOD_CK2_1 | 239 | 245 | PF00069 | 0.395 |
MOD_CK2_1 | 448 | 454 | PF00069 | 0.603 |
MOD_CK2_1 | 514 | 520 | PF00069 | 0.727 |
MOD_CK2_1 | 88 | 94 | PF00069 | 0.469 |
MOD_GlcNHglycan | 233 | 236 | PF01048 | 0.413 |
MOD_GlcNHglycan | 328 | 331 | PF01048 | 0.417 |
MOD_GlcNHglycan | 364 | 367 | PF01048 | 0.484 |
MOD_GlcNHglycan | 386 | 390 | PF01048 | 0.701 |
MOD_GlcNHglycan | 445 | 448 | PF01048 | 0.393 |
MOD_GlcNHglycan | 58 | 61 | PF01048 | 0.732 |
MOD_GlcNHglycan | 62 | 65 | PF01048 | 0.787 |
MOD_GSK3_1 | 16 | 23 | PF00069 | 0.547 |
MOD_GSK3_1 | 195 | 202 | PF00069 | 0.364 |
MOD_GSK3_1 | 213 | 220 | PF00069 | 0.203 |
MOD_GSK3_1 | 326 | 333 | PF00069 | 0.351 |
MOD_GSK3_1 | 378 | 385 | PF00069 | 0.707 |
MOD_GSK3_1 | 394 | 401 | PF00069 | 0.455 |
MOD_GSK3_1 | 457 | 464 | PF00069 | 0.479 |
MOD_GSK3_1 | 56 | 63 | PF00069 | 0.642 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.692 |
MOD_GSK3_1 | 84 | 91 | PF00069 | 0.378 |
MOD_N-GLC_1 | 414 | 419 | PF02516 | 0.283 |
MOD_NEK2_1 | 443 | 448 | PF00069 | 0.379 |
MOD_NEK2_1 | 84 | 89 | PF00069 | 0.495 |
MOD_NEK2_2 | 124 | 129 | PF00069 | 0.354 |
MOD_PIKK_1 | 448 | 454 | PF00454 | 0.476 |
MOD_PKA_1 | 323 | 329 | PF00069 | 0.377 |
MOD_PKA_2 | 372 | 378 | PF00069 | 0.640 |
MOD_PKA_2 | 448 | 454 | PF00069 | 0.336 |
MOD_Plk_1 | 117 | 123 | PF00069 | 0.423 |
MOD_Plk_1 | 406 | 412 | PF00069 | 0.395 |
MOD_Plk_4 | 217 | 223 | PF00069 | 0.403 |
MOD_Plk_4 | 255 | 261 | PF00069 | 0.346 |
MOD_Plk_4 | 301 | 307 | PF00069 | 0.329 |
MOD_Plk_4 | 336 | 342 | PF00069 | 0.315 |
MOD_Plk_4 | 434 | 440 | PF00069 | 0.396 |
MOD_Plk_4 | 47 | 53 | PF00069 | 0.302 |
MOD_Plk_4 | 85 | 91 | PF00069 | 0.385 |
MOD_ProDKin_1 | 140 | 146 | PF00069 | 0.335 |
MOD_ProDKin_1 | 299 | 305 | PF00069 | 0.275 |
MOD_SUMO_rev_2 | 338 | 346 | PF00179 | 0.288 |
TRG_DiLeu_BaLyEn_6 | 50 | 55 | PF01217 | 0.552 |
TRG_ENDOCYTIC_2 | 178 | 181 | PF00928 | 0.358 |
TRG_ENDOCYTIC_2 | 224 | 227 | PF00928 | 0.371 |
TRG_ENDOCYTIC_2 | 308 | 311 | PF00928 | 0.379 |
TRG_ENDOCYTIC_2 | 399 | 402 | PF00928 | 0.396 |
TRG_ENDOCYTIC_2 | 41 | 44 | PF00928 | 0.463 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.450 |
TRG_ER_diArg_1 | 372 | 374 | PF00400 | 0.384 |
TRG_ER_diArg_1 | 376 | 379 | PF00400 | 0.491 |
TRG_ER_diArg_1 | 487 | 490 | PF00400 | 0.529 |
TRG_ER_diArg_1 | 74 | 76 | PF00400 | 0.604 |
TRG_NES_CRM1_1 | 205 | 219 | PF08389 | 0.215 |
TRG_Pf-PMV_PEXEL_1 | 191 | 195 | PF00026 | 0.483 |
TRG_Pf-PMV_PEXEL_1 | 273 | 277 | PF00026 | 0.378 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6D4 | Leptomonas seymouri | 44% | 99% |
A0A0N0P991 | Leptomonas seymouri | 26% | 100% |
A0A0N0P992 | Leptomonas seymouri | 22% | 68% |
A0A0N0P9K9 | Leptomonas seymouri | 28% | 100% |
A0A0N1I2J8 | Leptomonas seymouri | 35% | 100% |
A0A0N1PCS4 | Leptomonas seymouri | 36% | 100% |
A0A0S4J7N0 | Bodo saltans | 26% | 100% |
A0A0S4KJL3 | Bodo saltans | 30% | 100% |
A0A1X0NUH5 | Trypanosomatidae | 22% | 89% |
A0A1X0NUJ5 | Trypanosomatidae | 27% | 100% |
A0A3Q8ICN0 | Leishmania donovani | 39% | 100% |
A0A3Q8IGQ2 | Leishmania donovani | 28% | 100% |
A0A3R7MUL5 | Trypanosoma rangeli | 25% | 94% |
A0A3S5H7R8 | Leishmania donovani | 25% | 68% |
A0A3S7X4R1 | Leishmania donovani | 41% | 100% |
A0A422P1E3 | Trypanosoma rangeli | 28% | 100% |
A4HJI7 | Leishmania braziliensis | 67% | 99% |
A4HJI8 | Leishmania braziliensis | 41% | 100% |
A4HJI9 | Leishmania braziliensis | 38% | 96% |
A4HKB3 | Leishmania braziliensis | 29% | 100% |
A4HKB4 | Leishmania braziliensis | 27% | 100% |
A4HKB5 | Leishmania braziliensis | 22% | 68% |
A4I6Y2 | Leishmania infantum | 99% | 100% |
A4I6Y3 | Leishmania infantum | 41% | 99% |
A4I6Y4 | Leishmania infantum | 39% | 100% |
A4I7U3 | Leishmania infantum | 28% | 100% |
A4I7U4 | Leishmania infantum | 25% | 68% |
A8Y5H7 | Mus musculus | 21% | 73% |
E9B204 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
E9B205 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 41% | 100% |
E9B206 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 39% | 100% |
E9B2Q1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E9B2Q2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 68% |
O43304 | Homo sapiens | 22% | 75% |
O76054 | Homo sapiens | 22% | 100% |
P58875 | Bos taurus | 22% | 100% |
Q03606 | Caenorhabditis elegans | 21% | 72% |
Q0V9N0 | Xenopus tropicalis | 22% | 74% |
Q4Q5F5 | Leishmania major | 24% | 68% |
Q4Q5F6 | Leishmania major | 28% | 100% |
Q4Q655 | Leishmania major | 39% | 100% |
Q4Q656 | Leishmania major | 40% | 99% |
Q4Q657 | Leishmania major | 88% | 99% |
Q92503 | Homo sapiens | 22% | 73% |
Q99J08 | Mus musculus | 22% | 100% |
Q99MS0 | Rattus norvegicus | 22% | 100% |
Q9UDX3 | Homo sapiens | 21% | 100% |
V5BL84 | Trypanosoma cruzi | 27% | 100% |
V5BQT0 | Trypanosoma cruzi | 24% | 94% |